Titration schedule planner

GLP-1 Titration Schedule Planner

Generate a personalized week-by-week titration calendar for any GLP-1 medication using the exact dose-escalation schedule from each drug's FDA Prescribing Information. Select your medication, choose a start date, and optionally indicate your current dose to see only the remaining schedule.

MedicationStart date

I'm already on a dose — show only the remaining schedule

Important: Your prescriber may adjust this schedule based on your tolerance. This is the standard FDA-label protocol — do not change doses without medical guidance. If side effects are intolerable at any step, contact your prescriber before the next increase.

Wegovy (semaglutide 2.4 mg) — titration calendar

Maintenance dose

2.4 mg weekly

Weeks to maintenance

16 weeks

First maintenance dose

Feb 2, 2027

Week	Date range	Dose	Pen color	Notes
1	Oct 13, 2026 — Oct 19, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
2	Oct 20, 2026 — Oct 26, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
3	Oct 27, 2026 — Nov 2, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
4	Nov 3, 2026 — Nov 9, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
5	Nov 10, 2026 — Nov 16, 2026	0.5 mg weekly	Red-violet
6	Nov 17, 2026 — Nov 23, 2026	0.5 mg weekly	Red-violet
7	Nov 24, 2026 — Nov 30, 2026	0.5 mg weekly	Red-violet
8	Dec 1, 2026 — Dec 7, 2026	0.5 mg weekly	Red-violet
9	Dec 8, 2026 — Dec 14, 2026	1 mg weekly	Yellow
10	Dec 15, 2026 — Dec 21, 2026	1 mg weekly	Yellow
11	Dec 22, 2026 — Dec 28, 2026	1 mg weekly	Yellow
12	Dec 29, 2026 — Jan 4, 2027	1 mg weekly	Yellow
13	Jan 5, 2027 — Jan 11, 2027	1.7 mg weekly	Teal
14	Jan 12, 2027 — Jan 18, 2027	1.7 mg weekly	Teal
15	Jan 19, 2027 — Jan 25, 2027	1.7 mg weekly	Teal
16	Jan 26, 2027 — Feb 1, 2027	1.7 mg weekly	Teal
17	Feb 2, 2027 — Feb 8, 2027	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
18	Feb 9, 2027 — Feb 15, 2027	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
19	Feb 16, 2027 — Feb 22, 2027	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
20	Feb 23, 2027 — Mar 1, 2027	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached

How the planner works

Every dose, duration, and pen color in this planner comes directly from the FDA Prescribing Information (PI) for each medication. The planner does not invent or modify doses — it generates a calendar view of the exact FDA-label protocol.

Wegovy (semaglutide) [1]: 16-week titration from 0.25 mg to 2.4 mg maintenance, in 4-week steps.
Ozempic (semaglutide) [2]: 4-week start at 0.25 mg, then 0.5 mg, with optional increases to 1.0 mg and 2.0 mg.
Zepbound / Mounjaro (tirzepatide) [3][4]: 16-week titration from 2.5 mg to 15 mg maximum, increasing by 2.5 mg every 4 weeks.
Foundayo (orforglipron) [5]: Daily oral tablet. 12-week titration from 3 mg to 36 mg maintenance.

Important warning

Your prescriber may adjust this schedule based on your tolerance. This is the standard FDA-label protocol. Do not change doses without medical guidance. If you are experiencing intolerable side effects at any dose level, contact your prescriber before your next scheduled increase — they may recommend staying at the current dose for additional weeks or reducing the dose.

What this planner does NOT do

It does not provide medical advice or replace a conversation with your prescriber.
It does not account for individual tolerance — the FDA labels include “as tolerated” language that your prescriber will apply to your situation.
It does not generate prescriptions or medication orders.
It does not track actual injection/pill dates — it shows the planned schedule for reference.

Important disclaimer

This planner is for educational purposes only and does not constitute medical advice or a prescription. The titration schedules shown are the standard FDA-label protocols. Your actual titration may differ based on your clinical response, tolerance, and your prescriber's judgment. Never adjust your medication dose without consulting your prescriber.

References

1.Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1: Recommended Dosage. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
2.Novo Nordisk. Ozempic (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s020lbl.pdf
3.Eli Lilly and Company. Zepbound (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s000lbl.pdf
4.Eli Lilly and Company. Mounjaro (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866Orig1s000lbl.pdf
5.Eli Lilly and Company. Foundayo (orforglipron) tablets — Prescribing Information. FDA / Drugs@FDA. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218226s000lbl.pdf

Related tools and research

GLP-1 Dose Plotter — visualize your dose history over time
GLP-1 Unit Converter — convert between mg, mL, and units
GLP-1 Missed Dose Guide — what to do if you miss a dose during titration
GLP-1 Weight Loss Calculator — week-by-week weight loss projections
Switching between GLP-1 medications — what happens to titration when you switch drugs
Semaglutide side effects: what to expect — the GI side effects that may affect titration pace
Side-effect timeline tool — when each side effect peaks and resolves, by drug and week. Slower titration shifts the peak; this tool shows what you avoid.